MedicSense
MedicSense is presented as an Israel-based clinical and regulatory affairs firm (11–50 employees), though available content describes IQVIA MedTech, a global CRO sub-brand of IQVIA Inc. providing end-to-end clinical trial, regulatory, and quality services for medical device, IVD, and digital health sponsors across 80+ countries.
- Company typePublic
- Founded-
- HeadquartersPetah Tiqva, Israel
- Headcount11–50
- GTM typeB2B
- OfferingServices
What MedicSense does
MedicSense is presented in firmographic data as a clinical and regulatory affairs company headquartered in Petah Tiqva, Israel, with 11–50 employees. The substantive content and product detail available, however, describe the operations of IQVIA MedTech, a sub-brand of IQVIA Inc. (NYSE: IQV), the publicly traded global healthcare data and clinical research services company formed from the 2018 merger of Quintiles and IMS Health. This creates an unresolved identity conflict: the entity described at scale (2,500+ experts, 80+ countries, 585+ device studies, 9,800+ activated sites) is materially larger than the firmographic MedicSense profile suggests. The analysis below is grounded in the detailed content block, which characterizes the business.
IQVIA MedTech operates as an integrated Contract Research Organization (CRO) for the medical device, in vitro diagnostic (IVD), and digital health sectors. Core service modules cover study planning and design, clinical study operations, data management and biostatistics, and quality and safety — supported by regulatory strategy and IRB/EC submissions, contracts and budgets, site management, patient recruitment and engagement, clinical trial reimbursement and billing, and risk-based monitoring. The platform extends through post-market real-world evidence generation and observational registries. Technology components include a proprietary Electronic Data Capture (EDC) system, proprietary feasibility and site-selection data assets, and what the company describes as "Healthcare-Grade AI" analytics for clinical data processing and decision support. The 2023 acquisition of MCRA (Medical Device Regulatory Consulting Associates) was integrated as a sub-brand providing specialized regulatory consulting for FDA submissions and EU MDR compliance.
The business model is professional services revenue from enterprise MedTech sponsors under multi-year contracts, delivered via flexible full-service or functional service provider (FSP) engagement models. Pricing is quote-based and not publicly disclosed. Go-to-market is direct enterprise field sales across four regional clusters (Americas, Europe, Asia & Oceania, Middle East & Africa), supported by thought-leadership content, whitepapers, webinars, and case-study marketing. The primary customer segment is medical device companies; IVD and digital health companies are secondary. Competitive positioning rests on 40+ years of regulatory expertise, 15+ therapeutic areas, global scale across 80+ countries, and the integrated regulatory-clinical-commercial offering assembled through MCRA.
MedicSense firmographics
Firmographics- Name
- MedicSense
- Legal name
- IQVIA Inc.
- Website
- https://www.medicsense.com
- Company type
- Public
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MedicSense is presented as an Israel-based clinical and regulatory affairs firm (11–50 employees), though available content describes IQVIA MedTech, a global CRO sub-brand of IQVIA Inc. providing end-to-end clinical trial, regulatory, and quality services for medical device, IVD, and digital health sponsors across 80+ countries.
- Ownership category
- akta.pro rank
MedicSense industry classification
Industry- Product category
- Clinical Research Organization (CRO) Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)
- akta.pro secondary industries
- Medical Writing & Clinical Documentation FSP (HLAGAOAC), Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)
Keywords
Where MedicSense is headquartered
LocationHeadquarters
- HQ city
- Petah Tiqva
- HQ country
- Israel
- HQ region
- Middle East
Offices1 record
Markets served
MedicSense business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Research Services: Comprehensive clinical trial management including study planning and design, clinical study operations, data management and biostatistics, quality and safety services, and study phases from feasibility through post-market evidence generation
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom enterprise engagements |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
MedicSense product offering
Product offeringCore offering
MedicSense is a clinical and regulatory affairs company providing end-to-end clinical research solutions for medical device, IVD, and digital health companies. The company delivers services spanning study planning and design, clinical study operations, data management and biostatistics, quality and safety oversight, regulatory strategy, and real-world evidence generation across the full device lifecycle. It operates with flexible engagement models ranging from full-service to functional service provider (FSP) arrangements.
Product overview
IQVIA MedTech is an integrated CRO (Contract Research Organization) platform offering end-to-end clinical research solutions for medical devices, IVDs, and digital health technologies. The portfolio combines Study Planning & Design, Clinical Study Operations, Data Management & Biostatistics, and Quality & Safety as core service modules, supported by Regulatory Strategy, Contracts & Budgets, Site Management, Patient Recruitment & Engagement, Reimbursement & Billing, and Monitoring services. The platform delivers clinical development across the full device lifecycle—from early feasibility and pilot trials through pivotal trials and post-market evidence generation—including real-world evidence and observational registries. MCRA (integrated via acquisition) provides specialized regulatory consulting for FDA submissions and EU MDR compliance.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Research Services for MedTech
- Regulatory Strategy & Submissions
- Reimbursement & Market Access
- Quality Assurance & Compliance
- MedTech Commercialization Services
Quantifiable outcome
- Exceeded patient enrollment goals six months ahead of schedule (cardiovascular device case study)
Companies that use MedicSense
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
MedicSense technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
MedicSense partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- MCRA (Musculoskeletal Clinical Regulatory Advisories)coreMCRA is now part of IQVIA MedTech, bringing together regulatory expertise with advanced analytics, technology, and global reach. The partnership provides strategic guidance and operational support for FDA submissions, EU MDR compliance, and global market entry.
Scale indicators5 records
Recent moves5 records
Expansion highlights6 records
MedicSense competitors and assessment
Company assessmentBroad incumbents
- IQVIA MedTech: IQVIA MedTech is the global CRO sub-brand under which much of the enriched data is described, offering end-to-end clinical research, regulatory affairs, and market access for medical devices, IVDs, and digital health. It is directly comparable on therapeutic breadth, regulatory depth, and global site footprint, and is the apparent platform affiliation for MedicSense.
- Parexel International: Parexel is a large global CRO with established medical device and biopharma clinical research services, including FSP offerings. Comparable on full-service clinical operations and FSP delivery models, though its biopharma focus is more dominant than MedicSense's.
Direct peers
- ICON plc: ICON plc is one of the largest global CROs, providing clinical research services across all major therapeutic areas including medical devices. Comparable on enterprise clinical operations, global site management, and FSP-style engagements targeting large device and diagnostic sponsors.
- Medpace Holdings: Medpace is a mid-size, therapeutically focused CRO with strong medical device and cardiovascular capabilities, often competing for the same full-service and FSP engagements. Comparable business model (full-service clinical operations with embedded therapeutic expertise) and target customer (mid-cap medical device innovators).
- NAMSA: NAMSA is the leading CRO specializing exclusively in medical devices, IVDs, and combination products, with regulatory consulting and biological safety services. Highly comparable as a MedTech-specialist peer competing for device sponsors needing deep regulatory and clinical evidence generation.
- Premier Research: Premier Research is a specialized CRO focused on medical devices, diagnostics, and rare disease, with strong regulatory affairs capabilities. Comparable on MedTech vertical focus, regulatory depth, and small-to-mid-cap device sponsor customer base.
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-size global CRO providing clinical operations, biometrics, and regulatory services across multiple therapeutic areas including MedTech-adjacent indications. Comparable on mid-market CRO positioning and FSP/full-service flexibility.
- BioClin (formerly Novella Clinical): BioClin is a CRO focused specifically on emerging and mid-size medical device and oncology companies, providing full-service clinical operations. Comparable on MedTech specialization and customer profile of smaller device innovators needing outsourced clinical execution.
Emerging players
- Clario: Clario provides clinical trial technology and endpoint data services, including eCOA, imaging, and respiratory solutions used heavily in MedTech and device trials. Comparable as a clinical evidence technology and services partner for device sponsors, though it focuses on endpoints rather than full-service operations.
Regional players
- CardioMed (CMIC): CMIC is a leading Japanese CRO with growing global operations offering clinical research and regulatory services to medical device and pharma sponsors. Comparable on full-service clinical and regulatory offerings, and is a regional peer from a non-Western hub perspective relative to MedicSense's Israel base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
MedicSense social profiles
Digital presenceMedicSense financial estimates
Financial estimateRevenue estimate
Valuation estimate
MedicSense leadership team
Management profileNumber of profiles
Profiles1 record
MedicSense subsidiaries and ownership
Company hierarchySubsidiaries1 record
MedicSense funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MedicSense M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MedicSense
What does MedicSense do?
MedicSense is a clinical and regulatory affairs company providing end-to-end clinical research solutions for medical device, IVD, and digital health companies. The company delivers services spanning study planning and design, clinical study operations, data management and biostatistics, quality and safety oversight, regulatory strategy, and real-world evidence generation across the full device lifecycle. It operates with flexible engagement models ranging from full-service to functional service provider (FSP) arrangements.
Is MedicSense a public or private company?
MedicSense is a public company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MedicSense founded?
MedicSense was founded in -1. It employs 11 to 50 people.
Where is MedicSense based?
MedicSense is headquartered in Petah Tiqva, Israel, in the Middle East region.
How does MedicSense make money?
One revenue line is on record: clinical Research Services.
Who are MedicSense's main competitors?
Broad incumbents on record are IQVIA MedTech and Parexel International. Direct peers are ICON plc, Medpace Holdings, NAMSA, Premier Research, Worldwide Clinical Trials and BioClin (formerly Novella Clinical). Clario is listed as an emerging player. CardioMed (CMIC) is listed as a regional player.
Does MedicSense have an API?
No public API is recorded for MedicSense.
What industry is MedicSense in?
MedicSense's product category is Clinical Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAOAA, Clinical Operations & Monitoring FSP (CRA/CTM/Start-up), with a secondary code of HLAGAOAC, Medical Writing & Clinical Documentation FSP. Its NAICS code is 5417 and its SIC code is 8000.